Inari Medical
Stock Forecast, Prediction & Price Target
Inari Medical (NARI) stock Price Target by analysts
$65.43
Potential downside: -18.19%
Inari Medical price prediction
What is Inari Medical stock analysts` prediction?
Inari Medical stock forecast: Based on 5 Wall Street analysts` predicted price targets for Inari Medical in the last 3 months, the avarage price target is $65.43, with a high forecast of $NaN. The average price target represents a -18.19% change from the last price of $79.98.
Disclaimer: This is not investment advice. Don't use price targets as the only investment indicator. Always remember to do your own thorough research and due diligence before making an investment decision.
Inari Medical stock Price Target by analysts
Full breakdown of analysts given Inari Medical price targets
| Analyst name & company | Analyst win rate | Publish date | Price target | Price when posted | Source | Historical targets |
|---|---|---|---|---|---|---|
Richard Newitter Truist Financial | 0% 0/3 | 9 months ago | $63 -21.22% downside | $55.03 | TheFly | Previous targets (2) |
David Rescott Robert W. Baird | 0% 0/3 | 11 months ago | $67 -16.22% downside | $49.27 | StreetInsider | Previous targets (2) |
Adam Maeder Piper Sandler | 0% 0/2 | 11 months ago | $52 -34.98% downside | $42.56 | TheFly | Previous targets (1) |
Richard Newitter Truist Financial | 0% 0/3 | 11 months ago | $50 -37.48% downside | $42.56 | StreetInsider | Previous targets (2) |
Marie Thibault BTIG | 0% 0/1 | 11 months ago | $86 7.52% upside | $42.56 | StreetInsider | Previous targets (0) |
William Plovanic Canaccord Genuity | 0% 0/1 | 11 months ago | $74 -7.47% downside | $42.56 | StreetInsider | Previous targets (0) |
David Rescott Robert W. Baird | 0% 0/3 | 12 months ago | $66 -17.47% downside | $42.2 | StreetInsider | Previous targets (2) |
Mathew Blackman Stifel Nicolaus | 0% 0/1 | about 1 year ago | $50 -37.48% downside | $44.1 | TheFly | Previous targets (0) |
Pito Chickering Deutsche Bank | 0% 0/1 | about 1 year ago | $68 -14.97% downside | $48.72 | StreetInsider | Previous targets (0) |
David Rescott Robert W. Baird | 0% 0/3 | about 1 year ago | $63 -21.22% downside | $52.11 | TheFly | Previous targets (2) |
Larry Biegelsen Wells Fargo | 0% 0/1 | about 1 year ago | $65 -18.72% downside | $52.11 | TheFly | Previous targets (0) |
Richard Newitter Truist Financial | 0% 0/3 | about 1 year ago | $60 -24.97% downside | $54.97 | TheFly | Previous targets (2) |
Adam Maeder Piper Sandler | 0% 0/2 | over 1 year ago | $50 -37.48% downside | $44.3 | StreetInsider | Previous targets (1) |
Unknown Morgan Stanley | N/A | over 2 years ago | $83 3.77% upside | $66.7 | Benzinga | N/A |
Unknown Truist Financial | N/A | almost 3 years ago | $75 -6.22% downside | $67.13 | Benzinga | N/A |
Unknown Canaccord Genuity | N/A | about 3 years ago | $94 17.53% upside | $68.65 | Benzinga | N/A |
Unknown Morgan Stanley | N/A | about 3 years ago | $93 16.28% upside | $73.52 | Benzinga | N/A |
Unknown BTIG | N/A | over 3 years ago | $100 25.03% upside | $72.32 | Benzinga | N/A |
Inari Medical Financial Estimates
Inari Medical Revenue Estimates
Inari Medical EBITDA Estimates
Inari Medical Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $276.98M N/A | $383.47M 38.44% | $493.63M 28.72% | Avg: $705.43M Low: $698.42M High: $708.75M avg. 42.90% | Avg: $824.70M Low: $818.08M High: $832.85M avg. 16.90% | Avg: $1.00B Low: $993.09M High: $1.01B avg. 21.39% | Avg: $1.15B Low: $1.14B High: $1.16B avg. 15.34% |
Net Income
% change YoY
| $9.84M N/A | $-29.26M -397.42% | $-1.63M 94.41% | Avg: $8.21M Low: $3.21M High: $12.46M avg. 602.11% | Avg: $28.58M Low: $19.30M High: $40.87M avg. 247.91% | Avg: $55.82M Low: $55.24M High: $56.54M avg. 95.32% | Avg: $94.23M Low: $93.25M High: $95.45M avg. 68.81% |
EBITDA
% change YoY
| $10.98M N/A | $-18.77M -270.96% | $15.18M 180.90% | Avg: $22.72M Low: $22.50M High: $22.83M avg. 49.66% | Avg: $26.57M Low: $26.35M High: $26.83M avg. 16.90% | Avg: $32.25M Low: $31.99M High: $32.57M avg. 21.39% | Avg: $37.20M Low: $36.90M High: $37.57M avg. 15.34% |
EPS
% change YoY
| $0.2 N/A | -$0.55 -375% | -$0.03 94.76% | Avg: $0.14 Low: $0.06 High: $0.22 avg. 591.90% | Avg: $0.49 Low: $0.34 High: $0.72 avg. 243.05% | Avg: $0.98 Low: $0.97 High: $1 avg. 102.33% | Avg: $1.66 Low: $1.64 High: $1.68 avg. 68.81% |
Operating Expenses
% change YoY
| $241.38M N/A | $367.06M 52.06% | $448.59M 22.21% | Avg: $496.57M Low: $491.64M High: $498.91M avg. 10.69% | Avg: $580.53M Low: $575.86M High: $586.27M avg. 16.90% | Avg: $704.72M Low: $699.06M High: $711.69M avg. 21.39% | Avg: $812.89M Low: $806.36M High: $820.93M avg. 15.34% |
FAQ
What is Inari Medical stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 253.54% in 2025-2028.
We have gathered data from 6 analysts. Their low estimate is 3.21M, average is 8.21M and high is 12.46M.
What is Inari Medical stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 24.13% in 2025-2028.
We have gathered data from 8 analysts. Their low revenue estimate is $698.42M, average is $705.43M and high is $708.75M.
What is Inari Medical stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 251.52% in 2025-2028.
We have gathered data from 6 analysts. Their low earnings per share estimate is $0.06, average is $0.14 and high is $0.21.
What is the best performing analyst?
In the last twelve months 5 analysts have been covering Inari Medical stock. The most successful analyst is Richard Newitter.